Story perspectives

Telomir-1 Promises Breakthrough in Aggressive Prostate Cancer Treatment

10/24/2025

38 6

Summary

Story summary

Telomir Pharmaceuticals announced preclinical data showing Telomir-1 can reset cancer defenses in aggressive prostate cancer models.
The study centers on two genes, CASP8 and GSTP1, which regulate cell death and detoxification.
Telomir-1, when combined with chemotherapy, reduced the methylation of CASP8 and GSTP1, suggesting it may counteract chemotherapy-related epigenetic silencing.
This modulation of apoptosis and detoxification pathways could enhance cancer treatment strategies.

1 of 1

Story summary

Telomir Pharmaceuticals announced preclinical data showing Telomir-1 can reset cancer defenses in aggressive prostate cancer models.
The study centers on two genes, CASP8 and GSTP1, which regulate cell death and detoxification.
Telomir-1, when combined with chemotherapy, reduced the methylation of CASP8 and GSTP1, suggesting it may counteract chemotherapy-related epigenetic silencing.
This modulation of apoptosis and detoxification pathways could enhance cancer treatment strategies.